Chicken or the egg: the dilemma of allergic rhinitis versus adenoid hypertrophy

Rhinology
|June 2, 2015
PubMed

Insights

Allergic rhinitis (AR) and adenoid hypertrophy (AH) are inversely related in children. Allergy symptoms like itching and sneezing, along with nasal secretions, help predict AR, not AH.

Area of Science:

  • Pediatric Otolaryngology
  • Allergy and Immunology

Background:

  • The relationship between allergic rhinitis (AR) and adenoid hypertrophy (AH) lacks scientific consensus.
  • Investigating the role of allergy in pediatric adenoid hypertrophy is crucial for understanding upper airway conditions.

Purpose of the Study:

  • To evaluate the role of allergy in the development of adenoid hypertrophy (AH) in children.
  • To explore the diagnostic utility of nasal endoscopy and patient history in identifying allergic rhinitis (AR) in children.

Main Methods:

  • A cohort of 155 children was studied between January and September 2013.
  • Skin prick testing was performed to assess allergic sensitization.
  • Nasal endoscopy and patient-reported symptoms (itching, sneezing) were analyzed.

Main Results:

  • A significant negative correlation was observed between adenoid hypertrophy (AH) and allergic rhinitis (AR).
  • Positive skin prick tests were found in 65.2% of children, with 75.2% showing multiple allergen sensitivity.
  • Itching, sneezing, and nasal secretion characteristics were significant predictors for diagnosing AR.

Conclusions:

  • Adenoid hypertrophy (AH) and allergic rhinitis (AR) are inversely associated in the pediatric population.
  • Clinical indicators such as nasal secretions, itching, and sneezing are valuable in the empirical diagnosis of AR in children.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
15.6K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.3K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.8K
Allergic Reactions02:06

Allergic Reactions

Overview
34.1K